Cochrane: PARP inhibitors improve survival in HER2-negative, BRCA-mutated breast cancer (of 11) Pediatric News , 02 Jun 2021 Key clinical point: In patients with locally advanced or metastatic human epidermal growth factor receptor 2 (HER2)-negative…